IGC PHARMA, INC. Other Non-Current Assets
IGC PHARMA, INC. (IGC) had Other Non-Current Assets of $656.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-14
- 2026-06-30: Other Assets, Noncurrent $656.00K.
- 2026-03-31: Other Assets, Noncurrent $659.00K.
- 2025-12-31: Other Assets, Noncurrent $669.00K.
- 2025-09-30: Other Assets, Noncurrent $672.00K.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $656.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $659.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $669.00K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $672.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $680.00K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $681.00K 10-KT · filed 2026-03-18 | |
| 2024-12-31 | $681.00K 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $687.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $688.00K 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $688.00K 10-K · filed 2025-06-27 | |
| 2023-12-31 | $999.00K 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $998.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.02M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $1.00M 10-K · filed 2024-06-24 | |
| 2022-12-31 | $1.03M 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $950.00K 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $922.00K 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $937.00K 10-K · filed 2023-07-07 | |
| 2021-12-31 | $612.00K 10-Q · filed 2022-02-10 | |
| 2021-09-30 | $611.00K 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $596.00K 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $603.00K 10-K · filed 2022-06-23 | |
| 2020-12-31 | $619.00K 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $616.00K 10-Q · filed 2020-11-20 | |
| 2020-06-30 | $606.00K 10-Q · filed 2020-08-19 | |
| 2020-03-31 | $610.00K 10-K · filed 2021-06-14 | |
| 2019-12-31 | $868.00K 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $867.00K 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $895.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $878.00K 10-K · filed 2020-07-13 | |
| 2018-12-31 | $787.00K 10-Q · filed 2019-02-12 | |
| 2018-09-30 | $819.00K 10-Q · filed 2018-10-16 | |
| 2018-06-30 | $460.41K 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $484.00K 10-K · filed 2019-06-14 | $484.56K 10-K · filed 2018-06-21 |
| 2017-12-31 | $820.91K 10-Q · filed 2018-02-20 | |
| 2017-09-30 | $691.75K 10-Q · filed 2017-11-17 | |
| 2017-06-30 | $672.14K 10-Q · filed 2017-08-18 | |
| 2017-03-31 | $539.72K 10-K · filed 2018-06-21 | |
| 2016-12-31 | $491.00K 10-Q · filed 2017-02-21 | |
| 2016-09-30 | $504.06K 10-Q · filed 2016-11-21 | |
| 2016-06-30 | $497.63K 10-Q · filed 2016-08-16 | |
| 2016-03-31 | $507.30K 10-K · filed 2017-07-14 | |
| 2015-12-31 | $410.16K 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $414.48K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $426.93K 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $434.28K 10-K · filed 2016-07-14 | |
| 2014-12-31 | $434.36K 10-Q · filed 2015-02-12 | |
| 2014-09-30 | $446.01K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $459.83K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $458.58K 10-K · filed 2015-07-14 | |
| 2013-12-31 | $400.34K 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $396.12K 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $426.95K 10-Q · filed 2013-08-16 | |
| 2013-03-31 | $466.11K 10-K · filed 2014-07-15 | |
| 2012-12-31 | $977.50K 10-Q · filed 2013-02-13 | |
| 2012-09-30 | $1.05M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $994.01K 10-Q/A · filed 2012-08-21 | |
| 2012-03-31 | $998.82K 10-K · filed 2014-07-15 | |
| 2011-12-31 | $246.86K 10-Q · filed 2012-02-16 | |
| 2011-09-30 | $145.72K 10-Q · filed 2011-11-18 | |
| 2011-06-30 | $291.87K 10-Q · filed 2011-08-18 | |
| 2011-03-31 | $748.62K 10-K · filed 2012-07-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |